Gastrointestinal cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with histologically confirmed or clinically suspected advanced cancer of following descriptions; 1.gastric or gastro-esophageal junction adenocarcinoma 2.Esophageal cancer(adenocarcinoma or squamous cell carcinoma) 3.Others (adenocarcinoma of small intestine, appendiceal adenocarcinoma, anal cancer, neuroendocrine carcinoma which includes mixed type with adenocarcinoma) 2) Planned to receive systemic chemotherapy for advanced disease 3) Presence or ability to acquire sufficient DNA for target sequencing 4) Written informed consent was obtained
Exclusion criteria
Exclusion criteria: 1) Patient is judged by the investigator to be inappropriate for study participation for any reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency or characteristics of cancer genome alteration | — |
Secondary
| Measure | Time frame |
|---|---|
| Association between each cancer genome alterations and clinicopathological characteristics or prognosis,Quality of the specimen contributing to gene analysis | — |
Countries
Japan
Contacts
National Cancer Center Hospital East Gastrointestinal Oncology Division